MLTX STOCK: MoonLake Immunotherapeutics Sued for Securities Fraud after Drug Trial Results Cause 90% Stock Drop — Investors Notified to Contact BFA Law
MLTX STOCK: MoonLake Immunotherapeutics Sued for Securities Fraud after Drug Trial Results Cause 90% Stock Drop — Investors Notified to Contact BFA Law GlobeNewswire November 19, 2025 NEW YORK, Nov. 19, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: […]